Skip to main content
AVANOS MEDICAL, INC. logo

AVANOS MEDICAL, INC. — Investor Relations & Filings

Ticker · AVNS ISIN · US40650V1008 LEI · 549300YCXWOM7NEWMQ58 US Manufacturing
Open in API
Filings indexed 673 across all filing types
Latest filing 2021-11-02 Interim / Quarterly Rep…
Country US United States of America
Listing US AVNS

About AVANOS MEDICAL, INC.

https://avanos.com/

Avanos Medical, Inc. is a medical technology company that develops, manufactures, and markets medical device solutions. The company's portfolio is focused on two primary segments: Pain Management & Recovery and Enteral Feeding. The Pain Management & Recovery division provides a range of non-opioid therapies and solutions for managing chronic and post-surgical pain, targeting specialties such as anesthesiology, orthopedics, and interventional pain management. The Enteral Feeding division offers a comprehensive portfolio of nutrition delivery systems and products for a wide spectrum of patients, from neonates and pediatrics to adults, supporting healthcare providers in critical and long-term care settings. The company is focused on delivering clinically superior solutions that improve patient outcomes and facilitate recovery.

Recent filings

Filing Released Lang Actions
FORM 10-Q
Interim / Quarterly Report Q3 2021
2021-11-02 English
FORM 8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The text specifically mentions "Item 2.02 Results of Operations and Financial Condition" and references a press release with financial results for the quarter ended September 30, 2021. However, the document itself does not contain detailed financial statements or substantive financial data; it only includes a press release as an exhibit and states that the information is being furnished and not filed. The document length is 3580 characters, which is relatively short and consistent with a current report filing. Given these factors, this is an initial announcement of quarterly financial results, which corresponds to an Earnings Release (ER).
2021-11-02 English
Regulatory Filings 2021
Regulatory Filings Classification · 95% confidence The provided document text appears to be encoded or encrypted and does not contain any readable content, keywords, regulatory headers, or references to specific report types, fiscal periods, or regulatory bodies. There is no indication of the document being a report itself or an announcement. Given the lack of identifiable information and the fallback rule for documents that do not fit any specific category, the appropriate classification is Regulatory Filings (RNS). The document length is 15,000 characters, which is substantial, but without meaningful content, it cannot be classified as a financial or corporate report.
2021-10-26 English
FORM 8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated September 29, 2021, reporting a change in senior management: the resignation of the Chief Accounting Officer and appointment of a new principal accounting officer. The key section is Item 5.02, which specifically covers departure and appointment of directors or certain officers. There is no financial data or earnings information, nor is this a report or announcement of a report publication. The document fits the definition of Board/Management Information (MANG) as it announces changes in senior management.
2021-10-05 English
FORM 4
Director's Dealing
2021-09-16 English
FORM 4/A
Director's Dealing
2021-09-10 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.